A Summary of the Myanmar Clinical Practice Guidelines for the Management of Obesity

Authors

  • Tint Swe Latt University of Medicine Yangon, Myanmar
  • Ko Ko University of Medicine Yangon, Myanmar
  • Than Than Aye University of Medicine Yangon, Myanmar
  • Aye Thidar University of Medicine Yangon, Myanmar
  • Ei Ei Khin University of Medicine Yangon, Myanmar

Abstract

There is a significant prevalence of overweight and obesity in Myanmar. It is anticipated that this will impact on the morbidity associated with other lifestyle diseases such as hypertension, Type 2 diabetes and various types of cancer. Recognizing this public health concern, the Myanmar Society of Endocrinology and Metabolism (MSEM) organized a task force for the development of evidence based clinical practice guidelines on obesity.

Downloads

Download data is not yet available.

References

KoKoZaw, Tint SweLatt, et. al, The study of National and Regional levels of obesity in Myanmar. 2009.

Tint SweLatt, PhyuPhyuAung, TheingiThwin, KoKoZaw (2004). WHO STEPwise approach to NCD surveillance, Yangon Division, Myanmar (2003 – 2004).

MaungMaungThanHtike, Tint SweLatt, KoKoZaw Myanmar STEP survey 2009; WHO STEPS chronic disease risk factor surveillance. 2009

WHO, Geneva Obesity: Preventing and Managing the Global Epidemic. 2000.

WHO Global Recommendations on Physical Activity for Health. 2010.

Dietary Guideline Advisory Committee, USDA Dietary Guidelines for Americans 2010. www.dietaryguidelines.gov. 2010.

August GP, Caprio S, Fennoy I, Freemark M, et al. Prevention and Treatment of Pediatric Obesity: Journal of Clinical Endocrinology & Metabolism. 2008; 93 (12): 4576-4599.

Caveney E, Caveney BJ, Somaratne R, Turner R, Gourgiotis L Pharmaceutical interventions for obesity: A public health perspective. Diabetes, Obesity and Metabolism. 2011 13: 490–497.

Padwal RS, Majumdar SR Drug treatments for obesity: Orlistat, sibutramine, and rimonabant. Lancet. 2007;369: 71–77.

Santry HP, Gillen DL, Lauderdale DS Trends in bariatric surgical procedures.JAMA. 2005;294: 1909–1917.

SIGN guideline. Management of obesity: A national clinical guideline. 2010

WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 2000.

WHO. Appropriate Body-Mass Index for Asian populations and its implications for policy and intervention strategies. The Lancet, 2004; 363:157-163.

National Health & Medical Research Council (NHMRC). Clinical practice guidelines for the management of overweight and obesity in adults. 2003.

Downloads

Published

2014-05-28

How to Cite

Latt, T. S., Ko, K., Aye, T. T., Thidar, A., & Khin, E. E. (2014). A Summary of the Myanmar Clinical Practice Guidelines for the Management of Obesity. Journal of the ASEAN Federation of Endocrine Societies, 26(2), 105. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/78

Issue

Vol. 26 No. 2 (2011): November Issue

Section

Feature Articles

License

Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).

To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.

A written agreement shall be emailed to the requester should permission be granted.

Most read articles by the same author(s)

1 2 > >>